Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
Kanis, John A. (Australian Catholic University. Mary McKillop Health Institute)
Harvey, N. C. (University of Southampton. MRC Lifecourse Epidemiology Unit)
McCloskey, Eugene (MRC and Arthritis Research UK Centre for Integrated Research in Musculoskeletal Ageing Mellanby)
Bruyère, Olivier (University of Liège. World Health Organization Collaborating Center for the Public Health Aspects of Musculoskeletal Health and Aging, Department of Public Health, Epidemiology and Health Economics)
Veronese, Nicola (Neuroscience Institute (Pàdua, Itàlia). Aging Branch)
Lorentzon, Mattias (Sahlgrenska University Hospital (Suècia))
Cooper, Cyrus (University of Oxford. NIHR Musculoskeletal Biomedical Research Unit)
Rizzoli, Rene (Geneva University Hospitals (Ginebra, Suïssa))
Adib, Gemma (Syrian National Osteoporosis Society)
Al-Daghri, Nasser (King Saud University. Chair for Biomarkers of Chronic Diseases, Biochemistry Dept., College of Science)
Campusano, C. (Universidad de los Andes. Clinica Universidad de los Andes and Faculty of Medicine)
Chandran, Manju (Singapore General Hospital, ACADEMIA. Osteoporosis and Bone Metabolism Unit, Department of Endocrinology)
Dawson-Hughes, Bess (Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University)
Javaid, K. (University of Oxford. NIHR Musculoskeletal Biomedical Research Unit)
Jiwa, Famida (Osteoporosis Canada. Chair of the Committee of Patients Societies at the International Osteoporosis Foundation)
Johansson, Helena (Australian Catholic University. Mary McKillop Health Institute)
Lee, J. K. (Beacon International Specialist Centre, Petaling Jaya, Malaysia)
Liu, Emilia (Australian Catholic University. Mary McKillop Health Institute)
Messina, Osvaldo D. (Cosme Argerich. IRO Medical Research Center, Buenos Aires and Rheumatology section)
Mkinsi, Ouafa (Ibn Rochd University Hospital. Department of Rheumatology)
Pinto, Daniel (Northwestern University. Department of Medical Social Sciences, Feinberg School of Medicine)
Prieto-Alhambra, Daniel (Universitat Autònoma de Barcelona)
Saag, Kenneth G (University of Alabama at Birmingham)
Xia, W. (Chinese Academy of Medical Sciences)
Zakraoui, Leith (University Tunis Manar and Hôpital Mongi-Slim. Service de Rhumatologie)
Reginster, Jean-Yves (University of Liège. Department of Public Health, Epidemiology and Health Economics)

Data:	2020
Resum:	Guidance is provided in an international setting on the assessment and specific treatment of postmenopausal women at low, high and very high risk of fragility fractures. The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2019. This manuscript seeks to apply this in an international setting, taking additional account of further categorisation of increased risk of fracture, which may inform choice of therapeutic approach. Clinical perspective and updated literature search. The following areas are reviewed: categorisation of fracture risk and general pharmacological management of osteoporosis. A platform is provided on which specific guidelines can be developed for national use to characterise fracture risk and direct interventions.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Anabolic agents ; Fracture risk assessment ; FRAX ; Inhibitors of bone resorption ; Treatment of osteoporosis
Publicat a:	Osteoporosis International, Vol. 31 (2020) , p. 1-12, ISSN 1433-2965

DOI: 10.1007/s00198-019-05176-3
PMID: 31720707

12 p, 639.3 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats